Hyperuricemia
📧 Sign up to get email alerts when something new happens for Hyperuricemia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-19EMA Authorised: Febuxostat Viatris (previously Febuxostat Mylan) (febuxostat) — Viatris Limited
European Medicines Agency authorised Febuxostat Viatris for hyperuricemia and gout-related indications.
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Results: Uric Acid Lowering Trial in Youth Onset T2D [Phase 2]
Phase 2 trial results for an uric acid-lowering therapy in youth-onset type 2 diabetes; study is completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia [Phase 1, Phase 2]
Open-label pharmacokinetic, pharmacodynamic, and drug-drug interaction study of dotinurad with allopurinol in gout patients with hyperuricem…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Long-Term Risk of Gout in Living Kidney Donors
A completed clinical trial update assessing the long-term risk of gout among living kidney donors.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Identification and Characterization of At-risk MASLD in Turkish Adults
This completed clinical trial identifies and characterizes individuals at risk for Metabolic dysfunction-associated steatotic liver disease …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of SHR4640 tablets in combination with febuxostat 40 mg for primary gout and hyper…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial [Phase 4]
A Phase 4 clinical trial (SAVE-Care) is evaluating sodium-glucose cotransporter-2 inhibitors as a novel approach for gout care, and the stud…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: The Effects of a Probiotic Food Supplement in Hyperuricaemia [NA]
This clinical trial is evaluating the effects of a probiotic food supplement on hyperuricemia with or without gout and is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia [Phase 2]
Phase 2 clinical trial update for BR2251 tablets in primary gout with hyperuricemia; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Chronic Kidney Disease and Metabolic Disorders in the Elderly
This clinical trial at Chinese PLA General Hospital is studying chronic kidney disease and metabolic disorders in elderly patients; the stud…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of AR882 with a xanthine oxidase inhibitor co-administration in gout patients who …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia) [NA]
A prospective exploratory study evaluating the effectiveness of an exercise prescription decision support tool for managing the four high co…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Treat-to-target by Email During Urate-lowering Therapy in Gout [NA]
Clinical trial update from Assistance Publique - Hôpitaux de Paris on a treat-to-target, email-based management approach during urate-loweri…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease [Phase 1, Phase 2]
This clinical trial update reports a dose-escalation study of IG3018 in adults with hyperuricemia, with or without chronic kidney disease, a…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness [Phase 4]
Phase 4 clinical trial evaluating HLA-B*58:01-guided therapy for gout to assess effectiveness, safety, and cost-effectiveness; recruitment n…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Acute Effects of a Urate-lowering Bacterial Therapeutic on Small Intestinal Transcriptomics and Glycomics in Healthy Subjects [NA]
A clinical trial investigating the acute effects of a urate-lowering bacterial therapeutic on small intestinal transcriptomics and glycomics…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects [Phase 1]
Phase 1 clinical trial update assessing the safety and the effect of food on the single-dose bioavailability of F-02-2-Na in healthy adult s…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
A clinical trial is planned to screen for hyperuricemia in patients with metabolic-associated fatty liver disease (MAFLD); recruitment has n…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects [Phase 1]
A Phase 1 study is evaluating the safety, tolerability, and pharmacokinetics of oral F-02-2-Na tablets in adults with hyperuricemia with or …
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Effect of Dotinurad in Hyperuricemia With Hypertension [Phase 4]
A Phase 4 clinical trial evaluating dotinurad for hyperuricemia (with gout) and hypertension is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia [Phase 2]
A Phase 2 trial evaluated different doses of LC350189 for efficacy and safety in patients with gout and hyperuricemia; trial results have be…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Effectiveness of Digital Health Intervention on Community Health Care in Middle-aged and Older Population in Taiwan [NA]
A completed clinical trial from Chang Gung Memorial Hospital evaluating the effectiveness of a digital health intervention on community heal…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients [Phase 3]
LG Chem reports completion of a Phase 3, placebo-controlled trial of tigulixostat in patients with gout and hyperuricemia; the study status …
-
FDA label_change · 2025-10-16FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA granted a supplemental approval for ALLOPURINOL submitted by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. to update the prod…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults [Phase 3]
A Phase 3 clinical trial evaluating HR091506 tablets for gout with hyperuricemia in adults has completed.